24 HR nitroglycerin 0.3 MG/HR Transdermal System — RxCUI 899688
RxNorm drug concept · Semantic clinical drug
RxCUI 899688
Semantic clinical drug · SCD
● Current RxNorm concept 6 FDA products
6 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI899688
Official name24 HR nitroglycerin 0.3 MG/HR Transdermal System
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known as24 HR NTG 0.3 MG/HR Transdermal System; nitroglycerin 0.3 MG/HR 24HR Transdermal System; 24 HR TNG 0.3 MG/HR Transdermal System; nitroglycerin 0.3 MG/HR 24 HR Transdermal Patch
FDA products mapped6
Package NDCs mapped6
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Nitroglycerin Transdermal Patch: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- No — the nitroglycerin patch works too slowly for that. It's designed to prevent angina from happening in the first place, not to stop an attack once it starts. You should still ha...
- Can I use this patch to stop chest pain that's already started?
- Yes, the nightly break is essential. Wearing the patch around the clock causes your body to stop responding to it — this is called tolerance — and the patch can completely lose its...
- Do I really have to take the patch off every night? What happens if I just leave it on?
🕸️ Concept Web — How 24 HR nitroglycerin 0.3 MG/HR Transdermal System Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
24 HR nitroglycerin 0.3 MG/HR Transdermal System
RxCUI 899688 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Nitroglycerin
4917IN
-
Nitroglycerin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Nitro-Dur
202508BN
-
Nitro-Dur
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Nitroglycerin Transdermal System
1805880SCDF -
Nitroglycerin Topical Product
1159832SCDG -
Nitroglycerin Transdermal Product
1295573SCDG -
Nitroglycerin Transdermal System [Nitro-Dur]
1805902SBDF -
Nitro-Dur Topical Product
1183933SBDG -
Nitro-Dur Transdermal Product
1296141SBDG -
Transdermal System
316987DF -
Topical Product
1151122DFG - +1 more in this family
-
Nitroglycerin Transdermal System
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Nitroglycerin 0.3 MG/HR
899687SCDC -
24 HR nitroglycerin 0.3 MG/HR Transdermal System [Nitro-Dur]
899690SBD -
Nitroglycerin 0.3 MG/HR [Nitro-Dur]
899689SBDC
-
Nitroglycerin 0.3 MG/HR
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Nitroglycerin 0.3 MG/HR
SCDC · 899687 -
Nitroglycerin Transdermal System
SCDF · 1805880 -
Nitroglycerin Topical Product
SCDG · 1159832 -
Nitroglycerin Transdermal Product
SCDG · 1295573
Brand-Name Concepts
-
24 HR nitroglycerin 0.3 MG/HR Transdermal System [Nitro-Dur]
SBD · 899690 -
Nitroglycerin 0.3 MG/HR [Nitro-Dur]
SBDC · 899689 -
Nitroglycerin Transdermal System [Nitro-Dur]
SBDF · 1805902 -
Nitro-Dur Topical Product
SBDG · 1183933 -
Nitro-Dur Transdermal Product
SBDG · 1296141 -
Nitro-Dur
BN · 202508
📦 FDA Products & Package NDCs
6 products · 6 package NDCs
6 package NDCs map to RxCUI 899688 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 50742-0513-30 | 30 POUCH in 1 BOX, UNIT-DOSE (50742-513-30) / 1 PATCH in 1... | NITRO-DUR | Ingenus Pharmaceuticals, LLC | 2017-12-06 |
| 50742-0514-30 | 30 POUCH in 1 BOX, UNIT-DOSE (50742-514-30) / 1 PATCH in 1... | NITRO-DUR | Ingenus Pharmaceuticals, LLC | 2017-12-06 |
| 50742-0515-30 | 30 POUCH in 1 BOX, UNIT-DOSE (50742-515-30) / 1 PATCH in 1... | NITRO-DUR | Ingenus Pharmaceuticals, LLC | 2017-12-06 |
| 50742-0516-30 | 30 POUCH in 1 BOX, UNIT-DOSE (50742-516-30) / 1 PATCH in 1... | NITRO-DUR | Ingenus Pharmaceuticals, LLC | 2017-12-06 |
| 50742-0517-30 | 30 POUCH in 1 BOX, UNIT-DOSE (50742-517-30) / 1 PATCH in 1... | NITRO-DUR | Ingenus Pharmaceuticals, LLC | 2017-12-06 |
| 50742-0518-30 | 30 POUCH in 1 BOX, UNIT-DOSE (50742-518-30) / 1 PATCH in 1... | NITRO-DUR | Ingenus Pharmaceuticals, LLC | 2017-12-06 |
Observed labelers:
Ingenus Pharmaceuticals, LLC (6)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.